Curt Buttiker

Curt Buttiker is an experienced sales professional specializing in rare diseases and biotechnology. Currently serving as the Regional Sales Director at BridgeBio, Curt is focused on building a sales team in the South Central region in preparation for the launch of Acoramidis. Previously, as the Executive District Sales Manager at AstraZeneca, Curt led a rare disease sales team and was involved in the upcoming launch of Eplontersen. Curt's career includes significant roles at Mallinckrodt Pharmaceuticals, where several awards were earned, and positions in other pharmaceutical companies such as Otonomy, Sepracor, and GlaxoSmithKline, gaining expertise in various therapeutic areas. Curt holds a Bachelor's Degree in Business Administration and Management from Baker College of Flint.